🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesAnti-thrombotic properties of GLP-1 receptor activation — need advice Page 4

Anti-thrombotic properties of GLP-1 receptor activation — need advice

DadBodDave Wed, Jun 26, 2024 at 3:24 AM 18 replies 1,927 viewsPage 4 of 4
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Jun 30, 2024 at 8:50 PM#16
LibrarianMeg said:
It is worth asking what the claim would look like if it were false.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

23 21Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 20 others
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Jul 1, 2024 at 2:38 PM#17

Adding the clinical framing, because it changes how the question reads. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

Last edited: Jul 1, 2024 at 5:38 PM
24 22BrianDallas92, labquiet_amy, emily_PDX and 21 others
Reply Quote Save Share Report
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Jul 2, 2024 at 8:25 AM#18
carl_compliance said:
Start from the measurement rather than the conclusion.

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

Last edited: Jul 2, 2024 at 2:25 PM
25 23ZaraB_AL, JakeSmashed95, NauseaFreeNow and 22 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Jul 3, 2024 at 2:12 AM#19
carl_compliance said:
Start from the measurement rather than the conclusion.

Coming at carl_compliance’s question from a different direction. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Last edited: Jul 3, 2024 at 3:12 AM
26 24GraceAZ_72, carl_compliance, DanielChem_CHI and 23 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jul 3, 2024 at 7:58 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out.

Last edited: Jul 3, 2024 at 11:58 PM
48 21PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 45 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register